LUC7L2

Putative RNA-binding protein Luc7-like 2 · Q9Y383 · LUC7L2 on Sugi Atlas →

0 patent compounds predicted against LUC7L2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to LUC7L2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Explore the Role of NLRP7 in the Regulation of Progestereone Induced Decidualization of Human Endometrial Stroma Cells nanCOMPLETED
Timisnar - Biomarkers Substudy (Timisnar-mirna) nanUNKNOWN
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
New Signaling Pathway Targeting Systemic Lupus Erythematosus nanUNKNOWN
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Epidemiological and Genetic Studies of Body Mass Index nanCOMPLETED
Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy nanNOT_YET_RECRUITING
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Study of Leukocyte Populations in Patients With Chronic Inflammatory nanUNKNOWN
Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects) nanUNKNOWN
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Implication of Long Non-coding RNA CCDC144NL-AS1/Micro RNA-143-3p Axis Expression Level as Novel Signature in Colorectal Cancer nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
Neurogenetics Patient Registry nanRECRUITING
Autophagy Bladder Cancer nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage nanENROLLING_BY_INVITATION
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN
Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment nanUNKNOWN
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes nanCOMPLETED
Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor nanCOMPLETED
Role of Nitric Oxide in Diabetic Patients With Erectile Dysfunction nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a LUC7L2 binder may also engage these)

ProteinNameSimilarity
Q7TNC4 1.000 Q7TNC4 →
Q9NQ29 0.998 Q9NQ29 →
O95232 0.996 O95232 →
Q9CYI4 0.993 Q9CYI4 →
Q5SUF2 0.992 Q5SUF2 →
Q5R8W6 0.990 Q5R8W6 →
Q3SX41 0.985 Q3SX41 →
Q86X95 0.965 Q86X95 →
Q62376 0.963 Q62376 →
Q66II8 0.963 Q66II8 →
Q9DA19 0.962 Q9DA19 →
Q5ZI03 0.962 Q5ZI03 →
P08621 0.959 P08621 →
Q1JU68 0.959 Q1JU68 →
EIF3A Eukaryotic translation initiation factor 3 subunit A 0.959 landscape →
Q5RAD5 0.957 Q5RAD5 →
Q1RMR2 0.956 Q1RMR2 →
Q15696 0.955 Q15696 →
P50503 0.955 P50503 →
Q1RMU5 0.955 Q1RMU5 →
Q99L47 0.955 Q99L47 →
P52756 0.955 P52756 →
P09406 0.955 P09406 →
Q07866 0.954 Q07866 →
P83094 0.954 P83094 →
Q2HJ41 0.954 Q2HJ41 →
Q6PCR7 0.954 Q6PCR7 →
Q5U2T8 0.954 Q5U2T8 →
Q91YE7 0.954 Q91YE7 →
Q95168 0.954 Q95168 →